NIT
VIVO

NumerixS Investment Technologies’s Meridian Bioscience Inc VIVO Stock Holding History

NumerixS Investment Technologies’s Portfolio VIVO Stock Details VIVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-200
Closed -$3K – 1407
2017
Q1 		$3K Buy
+200
New +$2.8K ﹤0.01% 1132

Other funds holding VIVO

BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $71.6B AUM 29.66% 1-Year Est. Return
PP
Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

NumerixS Investment Technologies's VIVO Position: Q2 2017 in Review

NumerixS Investment Technologies sold out of Meridian Bioscience Inc (VIVO) in Q2 2017, closing a stake of 200 shares — an estimated $3K sold.

NumerixS Investment Technologies first reported a position in VIVO in Q1 2017 and held it in 1 quarter. The position peaked at $3K in Q1 2017. 170 funds tracked by Wall St. Rank hold VIVO as of Q2 2017.

  • NumerixS Investment Technologies reported no remaining Meridian Bioscience Inc position as of Q2 2017 after selling out during the quarter.
  • NumerixS Investment Technologies sold 200 Meridian Bioscience Inc shares in Q2 2017, an estimated $3K.
  • NumerixS Investment Technologies first reported a position in Meridian Bioscience Inc in Q1 2017 and held it in 1 quarter.
  • NumerixS Investment Technologies's Meridian Bioscience Inc position peaked at $3K in Q1 2017.
  • 170 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q2 2017.

Based on NumerixS Investment Technologies's 13F filing for Q2 2017, filed 9 Aug 2017.